Genetics and Life Insurance - Medical Underwriting and Social Policy Medical Underwriting and Social Policy
Afbeeldingen
Sla de afbeeldingen overArtikel vergelijken
Auteur:
Mark A Rothstein
- Engels
- Hardcover
- 9780262182362
- 09 april 2004
- 304 pagina's
Samenvatting
Experts discuss the economic, legal, and social issues surrounding the use of genetic testing in determining eligibility for life insurance. Insurance companies routinely use an individual's medical history and family medical history in determining eligibility for life insurance; this is part of the process of medical underwriting. Insurers have also long used genetic information, often derived from family history, in underwriting. But rapid advances in gene identification and genetic testing are changing the way we look at genetic information. Should the results of genetic testing (which might identify a predisposition toward disease not related to medical history) be available to life insurance medical underwriters? Few if any life insurers currently require genetic testing, but there are no laws or regulations prohibiting its use. Genetics and Life Insurance examines the complex economic, legal, and social issues surrounding the use of genetic information in life insurance underwriting. The contributors are legal scholars, representatives of the life insurance industry (including an actuary and an insurance physician), a geneticist, a genetic counselor, a philosopher, and a consumer advocate. They explore all aspects of an issue that has only recently drawn the attention of policymakers and the public. The book opens with a report on the results of a public opinion poll on genetics and life insurance. Succeeding chapters present the insurer perspective, a discussion of the economics of risk selection in life insurance, background information on the process of underwriting, a scientific analysis of genetic risks and mortality rates, a philosophical discussion of fairness and genetic underwriting, the viewpoints of consumers and genetics counselors, a comparison of different international policy approaches to the issue, and a legal analysis of antitrust implications when insurers collaborate in setting standards for medical underwriting. In the final chapter the editor addresses various policy options, examining the pros and cons of each one and assessing their political feasibility.
Productspecificaties
Wij vonden geen specificaties voor jouw zoekopdracht '{SEARCH}'.
Inhoud
- Taal
- en
- Bindwijze
- Hardcover
- Oorspronkelijke releasedatum
- 09 april 2004
- Aantal pagina's
- 304
- Illustraties
- Nee
Betrokkenen
- Hoofdauteur
- Mark A Rothstein
- Hoofdredacteur
- Mark A. Rothstein
- Tweede Redacteur
- Arthur L. Caplan
- Hoofduitgeverij
- Mit Press Ltd
Overige kenmerken
- Editie
- illustrated edition
- Extra groot lettertype
- Nee
- Studieboek
- Ja
- Verpakking breedte
- 159 mm
- Verpakking hoogte
- 32 mm
- Verpakking lengte
- 241 mm
- Verpakkingsgewicht
- 544 g
EAN
- EAN
- 9780262182362
Je vindt dit artikel in
- Categorieën
- Beschikbaarheid
- Leverbaar
- Boek, ebook of luisterboek?
- Boek
- Taal
- Engels
- Studieboek of algemeen
- Algemene boeken
Kies gewenste uitvoering
Bindwijze
: Hardcover
Prijsinformatie en bestellen
De prijs van dit product is 25 euro en 34 cent. Dit is een tweedehands product.Alleen tweedehands
Goed
1 - 2 weken
Verkoop door
Bogamo 12 - Boeken outlet
- Bestellen en betalen via bol
- Prijs inclusief verzendkosten, verstuurd door Bogamo 12 - Boeken outlet
- 30 dagen bedenktijd en gratis retourneren
Shop dit artikel
Rapporteer dit artikel
Je wilt melding doen van illegale inhoud over dit artikel:
- Ik wil melding doen als klant
- Ik wil melding doen als autoriteit of trusted flagger
- Ik wil melding doen als partner
- Ik wil melding doen als merkhouder
Geen klant, autoriteit, trusted flagger, merkhouder of partner? Gebruik dan onderstaande link om melding te doen.